alexa Human Amniotic Fluid Stem Cells From Third Trimester Cultured Under Hypoxia And Endothelial Differentiation: In Vitro And In Vivo Study
ISSN: 2157-7013

Journal of Cell Science & Therapy
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

4th World Congress on Cell Science & Stem Cell Research
June 24-26, 2014 Valencia Conference Centre, Valencia, Spain

Pozzobon M, Schiavo A A, Franzin C, Piccoli M, Spiro G, Urbani L, Bertin E, Albiero M4, Visentin S, Cosmi E, Fadini G P and De Coppi P
ScientificTracks Abstracts: J Cell Sci Ther
DOI: 10.4172/2157-7013.S1.028
H uman amniotic fluid stem (hAFS) cells represent an attractive cell source in regenerative medicine since their ability to differentiate in different cell types. In particular, in this work we aimed at further investigating this potential both in vitro and in vivo, in relation to gestation trimester and culture oxygen condition. Human amniotic fluids were collected during routine amniocentesis (2 nd trimester) and eligible caesarean sections (3 rd trimester), after informed consent. Fresh cells were plated, later adherent cells were positively selected for CD117 and resulting hAFS cells were further expanded both in normoxia (20% O 2 ) and hypoxia (5% O 2 ). Human AFS cells from both gestation trimesters cultured in normoxia and hypoxia did not shown significant differences in surface marker expression and cell cycle stages (flow cytometry analysis), but the proliferation rate was significantly higher at 5% O 2 for both 2 nd and 3 rd trimester. Independently from trimester and oxygen pressure, hAFS cells displayed a clear endothelial capacity both in vitro , and in vivo , after Matrigel plug assay and local injection in a mouse model of acute ischemia, where hAFS cells were able to rescue the blood flow. Interestingly, hAFS cells expressed even before endothelial induction the ETS factors ETV2, FLI1 and ERG1, which represent three master regulators of the endothelial molecular program. The endothelial dysfunction represent one of the major health problem since reduced vasodilation start a protrombic state associated with diabetes, renal and heart failure. Here we reported the clear endothelial regenerative potential of hAFS cells, in particular regarding cells obtained from the 3 rd trimester of gestation and cultured at 5% O , conditions that could ensure an easier recovery and a faster expansion before therapeutic application.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version